266 related articles for article (PubMed ID: 21239697)
1. Functional study of the vitamin K cycle in mammalian cells.
Tie JK; Jin DY; Straight DL; Stafford DW
Blood; 2011 Mar; 117(10):2967-74. PubMed ID: 21239697
[TBL] [Abstract][Full Text] [Related]
2. Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase.
Rishavy MA; Hallgren KW; Wilson L; Singh S; Runge KW; Berkner KL
Blood; 2018 Jun; 131(25):2826-2835. PubMed ID: 29592891
[TBL] [Abstract][Full Text] [Related]
3. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of warfarin resistance using transcription activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 cells.
Tie JK; Jin DY; Tie K; Stafford DW
J Thromb Haemost; 2013 Aug; 11(8):1556-64. PubMed ID: 23710884
[TBL] [Abstract][Full Text] [Related]
5. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
Cain D; Hutson SM; Wallin R
J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
[TBL] [Abstract][Full Text] [Related]
6. Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation.
Rishavy MA; Usubalieva A; Hallgren KW; Berkner KL
J Biol Chem; 2011 Mar; 286(9):7267-78. PubMed ID: 20978134
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of vitamin K epoxide reductase.
Tie JK; Stafford DW
Vitam Horm; 2008; 78():103-30. PubMed ID: 18374192
[TBL] [Abstract][Full Text] [Related]
8. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.
Hammed A; Matagrin B; Spohn G; Prouillac C; Benoit E; Lattard V
J Biol Chem; 2013 Oct; 288(40):28733-42. PubMed ID: 23928358
[TBL] [Abstract][Full Text] [Related]
9. The conversion of vitamin K epoxide to vitamin K quinone and vitamin K quinone to vitamin K hydroquinone uses the same active site cysteines.
Jin DY; Tie JK; Stafford DW
Biochemistry; 2007 Jun; 46(24):7279-83. PubMed ID: 17523679
[TBL] [Abstract][Full Text] [Related]
10. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction.
Wajih N; Hutson SM; Wallin R
J Biol Chem; 2007 Jan; 282(4):2626-35. PubMed ID: 17124179
[TBL] [Abstract][Full Text] [Related]
11. Warfarin and the vitamin K-dependent gamma-carboxylation system.
Wallin R; Hutson SM
Trends Mol Med; 2004 Jul; 10(7):299-302. PubMed ID: 15242675
[TBL] [Abstract][Full Text] [Related]
12. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats.
Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923
[No Abstract] [Full Text] [Related]
13. The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.
Wajih N; Sane DC; Hutson SM; Wallin R
J Biol Chem; 2004 Jun; 279(24):25276-83. PubMed ID: 15075329
[TBL] [Abstract][Full Text] [Related]
14. The vitamin K oxidoreductase is a multimer that efficiently reduces vitamin K epoxide to hydroquinone to allow vitamin K-dependent protein carboxylation.
Rishavy MA; Hallgren KW; Wilson LA; Usubalieva A; Runge KW; Berkner KL
J Biol Chem; 2013 Nov; 288(44):31556-66. PubMed ID: 23918929
[TBL] [Abstract][Full Text] [Related]
15. Functional Study of the Vitamin K Cycle Enzymes in Live Cells.
Tie JK; Stafford DW
Methods Enzymol; 2017; 584():349-394. PubMed ID: 28065270
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
[TBL] [Abstract][Full Text] [Related]
17. Dicoumarol: A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism.
Timson DJ
Curr Drug Targets; 2017; 18(5):500-510. PubMed ID: 26201483
[TBL] [Abstract][Full Text] [Related]
18. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2.
Chu PH; Huang TY; Williams J; Stafford DW
Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19308-13. PubMed ID: 17164330
[TBL] [Abstract][Full Text] [Related]
19. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
Fasco MJ; Hildebrandt EF; Suttie JW
J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
[TBL] [Abstract][Full Text] [Related]
20. Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
Czogalla KJ; Biswas A; Höning K; Hornung V; Liphardt K; Watzka M; Oldenburg J
Nat Struct Mol Biol; 2017 Jan; 24(1):77-85. PubMed ID: 27941861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
